Stelic Institute & Co Inc - Company Review
Stelic Institute & Co Inc - Company ReviewSummary
Stelic Institute & Co Inc (Stelic Institute) is a biotechnology company that discovers, validates and develops anti-fibrotic therapeutics. The company develops therapies for fibrosis and cancer. Its drug candidates include small molecule inhibitors targeting distinct glycogenes for life-style and age-related fibrosis and anti-glycogene RNAi therapeutics for intractable fibrosis. Stelic Institute also provides services such as technologies licensing, contract research services, and biotechnology and clinical research and development consulting. The company also provides treatment of drug-resistant and unresectable pancreatic cancer patients. It operates through research institute, universities and healthcare companies. Stelic Institute is headquartered in Minato, Japan.
This comprehensive company report of Stelic Institute & Co Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.